⏰ Last chance! Join Premium for $20/month before it increases to $49/month.

SAB Biotherapeutics, Inc. Common Stock

$3.03
+0.24 (+8.60%)

Volume:

183.055K ($554.51K)

Market Capitalization:

$275.69M

Live Price

Live Volume

Chart Volume 0
Volume 0
5 sec

SAB Biotherapeutics Market Segments

Regular Trading Hours

+0.23(+8.21%)
Open$2.80
Close$3.03
Low$2.80
Low Change0.00 (0.00%)
High$3.04
High Change+0.24 (+8.57%)
Range$0.24
Volume182.35K
Dollar Volume$552.52K

Premarket

-0.38(-11.88%)
Open$3.20
Close$2.82
Low$2.80
Low Change-0.40 (-12.50%)
High$3.20
High Change+0.00 (+0.00%)
Range$0.40
Volume705
Dollar Volume$1.99K

Overnight

*No Trades in Segment

After Hours Yesterday

-0.04(-1.43%)
Open$2.79
Close$2.75
Low$2.75
Low Change-0.04 (-1.43%)
High$2.79
High Change+0.00 (+0.00%)
Range$0.04
Volume29.09K
Dollar Volume$80.00K

Regular Trading Hours Yesterday

-0.03(-1.06%)
Open$2.82
Close$2.79
Low$2.77
Low Change-0.06 (-1.95%)
High$2.94
High Change+0.12 (+4.26%)
Range$0.18
Volume283.775K
Dollar Volume$791.73K

Premarket Yesterday

+0.12(+4.35%)
Open$2.82
Close$2.94
Low$2.80
Low Change-0.02 (-0.71%)
High$2.94
High Change+0.12 (+4.35%)
Range$0.14
Volume1K
Dollar Volume$2.94K

SAB Biotherapeutics News

There is no current news for this stock at the moment.

SAB Biotherapeutics Top Trades

SAB Biotherapeutics's top trade so far today returned +8.57%, while the top short trade returned -12.50%.

SAB Biotherapeutics Moving Averages

5 Day Moving Average (SMA5)$2.88
10 Day Moving Average (SMA10)$2.73
20 Day Moving Average (SMA20)$2.87
50 Day Moving Average (SMA50)$3.30
100 Day Moving Average (SMA100)$3.50
200 Day Moving Average (SMA200)$3.69

SAB Biotherapeutics Statistics

Average Volume (30 Days)584.18K
P/E Ratio (Current)-6.93
EPS (Current)-$0.43
Dividend Yield0.00%
Free Cash Flow-$57.44M
Cash Ratio0.71
Current Ratio9.22
Quick Ratio9.22
Debt to Equity0.01
Enterprise Value$266.07M
EV to EBITDA-3.87
EV to Sales—
Price to Book1.26
Price to Cash Flow—
Price to Free Cash Flow—
Price to Sales—
Return on Assets-0.16%
Return on Equity-0.18%

SAB Biotherapeutics Stock Splits

There has been 1 stock split for SAB Biotherapeutics (SABS). The reverse stock split occured on January 5, 2024 and reduced the outstanding shares at a ratio of 10:1.

DateTypeRatio
Jan 5, 2024Reverse10:1

SAB Biotherapeutics Dividends

There have been no dividends for SAB Biotherapeutics (SABS).